The growth of a variety of tumors are inhibited by indole-3-carbinol (I3C) obviously. But, its role in laryngeal cancer is not clear. The goal of this study was to research the probable roles that laryngeal cancer cell apoptosis and proliferation Hep-2 was influenced by I3C. I3C dose-dependently therapy obviously inhibited Hep-2cell proliferation, and, I3C promoted apoptosis and induced cell morphological changes at 100, 200, 300, 400 μM doses. We discovered that I3C shows anticancer effect through various signal pathways after Hep-2 cells I3C therapy. In Hep-2laryngeal cancer cell line, through decreasing cell cycle-related proteins that include cyclin D1, CDK6, CDK4, and pRb, G1 arrest was induced by I3C. Apart from this, BALB/c nude mice constructed tumor-bearing mouse models. BALB/c nude mice were divided into three groups: treated with I3C, untreated control group and pretreated with I3C. After 8 weeks treatment, the untreated control group developed bigger tumors compared to mice treated or pretreated with I3C, and in the tumors such as cyclin D1, CDK6, CDK4 and pRb cell cycle-related proteins were obviously decreased. Further, the study result showed there was no harmful side effect in the heart, liver and kidney of the I3C-treated nude mice. In conclusion, both in vivo and in vitro I3C inhibited proliferation and induced the Hep-2 cells apoptosis, and showed low toxicity to normal cells. By suppressing the expression of cyclin families and CDK, we deduce that I3C can inhibit the Hep-2 cells growth in vitro. On normal organs and tissues, the I3C had no toxic effects and was safe.
| Published in | Journal of Diseases and Medicinal Plants (Volume 5, Issue 2) |
| DOI | 10.11648/j.jdmp.20190502.11 |
| Page(s) | 22-28 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Laryngeal Cancer, Indole-3-carbinol, Cell Cycle, Apoptosis
| [1] | Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90. |
| [2] | Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH (2001) Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Oncogene 20: 2927–2936. |
| [3] | Nachshon-Kedmi M, Yannai S, Haj A, Fares FA (2003) Indole-3-carbinol and 3,3’-diindolylmethane induce apoptosis in human prostate cancer cells. Food Chem Toxicol 41: 745–752. |
| [4] | Hsu JC, Dev A, Wing A, Brew CT, Bjeldanes LF, et al. (2006) Indole-3-carbinol mediated cell cycle arrest of LNCaP human prostate cancer cells requires the induced production of activated p53 tumor suppressor protein. Biochem Pharmacol 72: 1714–1723. |
| [5] | Zhang J, Hsu BAJ, Kinseth BAM, Bjeldanes LF, Firestone GL (2003) Indole-3-carbinol induces a G1 cell cycle arrest and inhibits prostate-specific antigen production in human LNCaP prostate carcinoma cells. Cancer 98: 2511–2520. |
| [6] | Takada Y, Andreeff M, Aggarwal BB (2005) Indole-3-carbinol suppresses NFkappaB and IkappaBalpha kinase activation, causing inhibition of expression of NF-kappaB-regulated antiapoptotic and metastatic gene products and enhancement of apoptosis in myeloid and leukemia cells. Blood 106: 641–649. |
| [7] | Wu HT, Lin SH, Chen YH (2005) Inhibition of cell proliferation and in vitro markers of angiogenesis by indole-3-carbinol, a major indole metabolite present in cruciferous vegetables. J Agric Food Chem 53: 5164–5169. |
| [8] | Aggarwal BB, Ichikawa H (2005) Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 4: 1201–1215. |
| [9] | Ping J, Gao AM, Qin HQ, Wei XN, Bai J, et al. (2011) Indole-3-carbinol enhances the resolution of rat liver fibrosis and stimulates hepatic stellate cell apoptosis by blocking the inhibitor of kappaB kinase alpha/inhibitor of kappaBalpha/nuclear factor-kappaB pathway. J Pharmacol Exp Ther 339: 694–703. |
| [10] | Ping J, Li JT, Liao ZX, Shang L, Wang H (2011) Indole-3-carbinol inhibitshepatic stellate cells proliferation by blocking NADPH oxidase/reactive oxygenspecies/p38 MAPK pathway. Eur J Pharmacol 650: 656–662. |
| [11] | Zhao P, Fu J, Yao B, Hu E, Song Y, et al. (2013) Diethyl sulfate-induced cell cycle arrest and apoptosis in human bronchial epithelial 16HBE cells. ChemBiolInteract 205: 81–89. |
| [12] | Wu A, Luo W, Zhang Q, Yang Z, Zhang G, et al. (2013) Aldehydedehydrogenase 1, a functional marker for identifying cancer stem cells inhuman nasopharyngeal carcinoma. Cancer Lett 330: 181–189. |
| [13] | Yang Y, Liao Q, Wei F, Li X, Zhang W, et al. (2013) LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways. PLoS One 8: e62869. |
| [14] | Han JB, Tao ZZ, Chen SM, Kong YG, Xiao BK (2011) Adenovirus-mediated transfer of tris-shRNAs induced apoptosis of nasopharyngeal carcinoma cell in vitro and in vivo. Cancer Lett 309: 162–169. |
| [15] | Wang Y, Tao ZZ, Chen SM, Xiao BK, Zhou XH, et al. (2008) Application of combination of short hairpin RNA segments for silencing VEGF, TERT and Bcl-xl expression in laryngeal squamous carcinoma. Cancer Biol Ther 7: 896–901. |
| [16] | Xie Y, Li Y, Peng X, Henderson F Jr, Deng L, et al. (2013) Ikappa B kinase alpha involvement in the development of nasopharyngeal carcinoma through aNF-kappaB-independent and ERK-dependent pathway. Oral Oncol. |
| [17] | Ma BB, Chan AT (2005) Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma. Cancer 103: 22–31. |
| [18] | Xu Y, Zhang J, Dong WG (2011) Indole-3-carbinol (I3C)-induced apoptosis in nasopharyngeal cancer cells through Fas/FasL and MAPK pathway. Med Oncol 28: 1343–1348. |
| [19] | Zhu W, Li W, Yang G, Zhang Q, Li M, et al. (2010) Indole-3-carbinol inhibits nasopharyngeal carcinoma. Int J Toxicol 29: 185–192. |
| [20] | Liu DB, Hu GY, Long GX, Qiu H, Mei Q, et al. (2012) Celecoxib inducesapoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation. Acta Pharmacol Sin 33: 682–690. |
| [21] | Ong CS, Zhou J, Ong CN, Shen HM (2010) Luteolin induces G1 arrest inhuman nasopharyngeal carcinoma cells via the Akt-GSK-3beta-Cyclin D1pathway. Cancer Lett 298: 167–175. |
| [22] | Paggi MG, Baldi A, Bonetto F, Giordano A (1996) Retinoblastoma protein family in cell cycle and cancer: a review. J Cell Biochem 62: 418–430. |
| [23] | Aggarwal BB (2004) Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203–208. |
| [24] | Orlowski RZ, Baldwin AS Jr (2002) NF-kappaB as a therapeutic target in cancer. Trends Mol Med 8: 385–389. |
| [25] | Kim DS, Jeong YM, Moon SI, Kim SY, Kwon SB, et al. (2006) Indole-3-carbinol enhances ultraviolet B-induced apoptosis by sensitizing humanmelanoma cells. Cell Mol Life Sci 63: 2661–2668. |
| [26] | Anderton MJ, Jukes R, Lamb JH, Manson MM, Gescher A, et al. (2003) Liquid chromatographic assay for the simultaneous determination of indole-3-carbinol and its acid condensation products in plasma. J Chromatogr B Analyt Technol Biomed Life Sci 787: 281–291. |
| [27] | Reed GA, Arneson DW, Putnam WC, Smith HJ, Gray JC, et al. (2006) Singledose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,39-diindolylmethane. Cancer Epidemiol Biomarkers Prev 15: 2477–2481. |
| [28] | Reed GA, Peterson KS, Smith HJ, Gray JC, Sullivan DK, et al. (2005) A phase Istudy of indole-3-carbinol in women: tolerability and effects. Cancer Epidemiol Biomarkers Prev 14: 1953–1960. |
| [29] | Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal tohuman studies revisited. FASEB J 22: 659–661. |
APA Style
Chenggang Mao, Xiaochun Zhou, Yidao Jiang, Lijia Wan, Zezhang Tao. (2019). Indole-3-Carbinol Inhibits Laryngeal Cancer Growth Through Cell Cycle Arrest. Journal of Diseases and Medicinal Plants, 5(2), 22-28. https://doi.org/10.11648/j.jdmp.20190502.11
ACS Style
Chenggang Mao; Xiaochun Zhou; Yidao Jiang; Lijia Wan; Zezhang Tao. Indole-3-Carbinol Inhibits Laryngeal Cancer Growth Through Cell Cycle Arrest. J. Dis. Med. Plants 2019, 5(2), 22-28. doi: 10.11648/j.jdmp.20190502.11
AMA Style
Chenggang Mao, Xiaochun Zhou, Yidao Jiang, Lijia Wan, Zezhang Tao. Indole-3-Carbinol Inhibits Laryngeal Cancer Growth Through Cell Cycle Arrest. J Dis Med Plants. 2019;5(2):22-28. doi: 10.11648/j.jdmp.20190502.11
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.jdmp.20190502.11,
author = {Chenggang Mao and Xiaochun Zhou and Yidao Jiang and Lijia Wan and Zezhang Tao},
title = {Indole-3-Carbinol Inhibits Laryngeal Cancer Growth Through Cell Cycle Arrest},
journal = {Journal of Diseases and Medicinal Plants},
volume = {5},
number = {2},
pages = {22-28},
doi = {10.11648/j.jdmp.20190502.11},
url = {https://doi.org/10.11648/j.jdmp.20190502.11},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jdmp.20190502.11},
abstract = {The growth of a variety of tumors are inhibited by indole-3-carbinol (I3C) obviously. But, its role in laryngeal cancer is not clear. The goal of this study was to research the probable roles that laryngeal cancer cell apoptosis and proliferation Hep-2 was influenced by I3C. I3C dose-dependently therapy obviously inhibited Hep-2cell proliferation, and, I3C promoted apoptosis and induced cell morphological changes at 100, 200, 300, 400 μM doses. We discovered that I3C shows anticancer effect through various signal pathways after Hep-2 cells I3C therapy. In Hep-2laryngeal cancer cell line, through decreasing cell cycle-related proteins that include cyclin D1, CDK6, CDK4, and pRb, G1 arrest was induced by I3C. Apart from this, BALB/c nude mice constructed tumor-bearing mouse models. BALB/c nude mice were divided into three groups: treated with I3C, untreated control group and pretreated with I3C. After 8 weeks treatment, the untreated control group developed bigger tumors compared to mice treated or pretreated with I3C, and in the tumors such as cyclin D1, CDK6, CDK4 and pRb cell cycle-related proteins were obviously decreased. Further, the study result showed there was no harmful side effect in the heart, liver and kidney of the I3C-treated nude mice. In conclusion, both in vivo and in vitro I3C inhibited proliferation and induced the Hep-2 cells apoptosis, and showed low toxicity to normal cells. By suppressing the expression of cyclin families and CDK, we deduce that I3C can inhibit the Hep-2 cells growth in vitro. On normal organs and tissues, the I3C had no toxic effects and was safe.},
year = {2019}
}
TY - JOUR T1 - Indole-3-Carbinol Inhibits Laryngeal Cancer Growth Through Cell Cycle Arrest AU - Chenggang Mao AU - Xiaochun Zhou AU - Yidao Jiang AU - Lijia Wan AU - Zezhang Tao Y1 - 2019/06/04 PY - 2019 N1 - https://doi.org/10.11648/j.jdmp.20190502.11 DO - 10.11648/j.jdmp.20190502.11 T2 - Journal of Diseases and Medicinal Plants JF - Journal of Diseases and Medicinal Plants JO - Journal of Diseases and Medicinal Plants SP - 22 EP - 28 PB - Science Publishing Group SN - 2469-8210 UR - https://doi.org/10.11648/j.jdmp.20190502.11 AB - The growth of a variety of tumors are inhibited by indole-3-carbinol (I3C) obviously. But, its role in laryngeal cancer is not clear. The goal of this study was to research the probable roles that laryngeal cancer cell apoptosis and proliferation Hep-2 was influenced by I3C. I3C dose-dependently therapy obviously inhibited Hep-2cell proliferation, and, I3C promoted apoptosis and induced cell morphological changes at 100, 200, 300, 400 μM doses. We discovered that I3C shows anticancer effect through various signal pathways after Hep-2 cells I3C therapy. In Hep-2laryngeal cancer cell line, through decreasing cell cycle-related proteins that include cyclin D1, CDK6, CDK4, and pRb, G1 arrest was induced by I3C. Apart from this, BALB/c nude mice constructed tumor-bearing mouse models. BALB/c nude mice were divided into three groups: treated with I3C, untreated control group and pretreated with I3C. After 8 weeks treatment, the untreated control group developed bigger tumors compared to mice treated or pretreated with I3C, and in the tumors such as cyclin D1, CDK6, CDK4 and pRb cell cycle-related proteins were obviously decreased. Further, the study result showed there was no harmful side effect in the heart, liver and kidney of the I3C-treated nude mice. In conclusion, both in vivo and in vitro I3C inhibited proliferation and induced the Hep-2 cells apoptosis, and showed low toxicity to normal cells. By suppressing the expression of cyclin families and CDK, we deduce that I3C can inhibit the Hep-2 cells growth in vitro. On normal organs and tissues, the I3C had no toxic effects and was safe. VL - 5 IS - 2 ER -
Information
Email: